Results 361 to 370 of about 4,190,416 (396)
Some of the next articles are maybe not open access.

Dockey: a modern integrated tool for large-scale molecular docking and virtual screening

Briefings Bioinform., 2023
Molecular docking is a structure-based and computer-aided drug design approach that plays a pivotal role in drug discovery and pharmaceutical research. AutoDock is the most widely used molecular docking tool for study of protein-ligand interactions and ...
Lianming Du   +6 more
semanticscholar   +1 more source

Molecular Docking: Principles, Advances, and its Applications in Drug Discovery

Letters in Drug Design & Discovery, 2022
Molecular docking is a structure-based computational method that generates the binding pose and affinity between ligands and targets. There are many powerful docking programs. However, there is no single program that is suitable for every system. Hence,
M. T. Muhammed, Esin Aki-Yalcin
semanticscholar   +1 more source

Molecular Docking Algorithms

Current Drug Targets, 2008
By means of virtual screening of small molecules databases it is possible to identify new potential inhibitors against a target of interest. Molecular docking is a computer simulation procedure to predict the conformation of a receptor-ligand complex. Each docking program makes use of one or more specific search algorithms, which are the methods used ...
Walter Filgueira de Azevedo, Raquel Dias
openaire   +2 more sources

Molecular Docking

2021
Molecular docking describe the “best-fit” orientation of a ligand (lead) that binds to a particular target of ...
openaire   +2 more sources

Molecular Recognition and Docking Algorithms

Annual Review of Biophysics and Biomolecular Structure, 2003
▪ Abstract  Molecular docking is an invaluable tool in modern drug discovery. This review focuses on methodological developments relevant to the field of molecular docking. The forces important in molecular recognition are reviewed and followed by a discussion of how different scoring functions account for these forces.
Natasja Brooijmans, Irwin D. Kuntz
openaire   +3 more sources

Molecular Docking

2008
Molecular docking is a key tool in structural molecular biology and computer-assisted drug design. The goal of ligand-protein docking is to predict the predominant binding mode(s) of a ligand with a protein of known three-dimensional structure. Successful docking methods search high-dimensional spaces effectively and use a scoring function that ...
Garrett M, Morris, Marguerita, Lim-Wilby
openaire   +2 more sources

Molecular Docking Methodologies

2012
Molecular docking represents an important technology for structure-based drug design. Docking is a computational technique aimed at the prediction of the most favorable ligand-target spatial configuration and an estimate of the corresponding complex free energy, although as stated at the beginning accurate scoring methods remain still elusive.
Bortolato A.   +3 more
openaire   +2 more sources

InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening

Briefings Bioinform., 2020
Exploring protein-ligand interactions is a subject of immense interest, as it provides deeper insights into molecular recognition, mechanism of interaction and subsequent functions.
Taj Mohammad, Yash Mathur, M. Hassan
semanticscholar   +1 more source

Interfaces in Molecular Docking

Molecular Simulation, 2004
The Fast Atomic Density Evaluation (FADE) program analyzes shape complementarity using atomic density methods and fast Fourier transforms (FFT). Statistical results for 184 protein–protein and protein–DNA complexes are presented. Almost all of the interfaces studies were found to be complementary, and the average FADE complementarity score highlighted ...
Sharokina Shahbaz   +2 more
openaire   +2 more sources

Molecular Docking in Formulation and Development

Current Drug Discovery Technologies, 2019
Background:In pharmaceutical research drug discovery and development process is timeconsuming and expensive. In many cases, it produces incompetent results due to the failure of in vitro and in vivo conventional approaches. Before any new drug is placed in the market it must undergo rigorous testing to get FDA approval.
Tejinder Kaur   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy